Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
10.07%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 9.17Close
$ 8.1 - $ 25.15 52-Week Range
Ticker Information
Ticker
ANIKCompany Name
ANIKA THERAPEUTICS INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQANIKA THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ANIK - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 9.25M | 10.07% | $ 91.85M |
| 3/31/2025 | $ 9.81M | 9.3% | $ 105.55M |
| 12/31/2024 | $ 10.27M | 8.57% | $ 119.91M |
| 9/30/2024 | $ 12.04M | 7.34% | $ 164.17M |
| 6/30/2024 | $ 13.36M | 8% | $ 166.88M |
| 3/31/2024 | $ 14.98M | 8.85% | $ 169.26M |
| 12/31/2023 | $ 16.45M | 9.87% | $ 166.66M |
| 9/30/2023 | $ 16.47M | 10.08% | $ 163.31M |
| 6/30/2023 | $ 16.4M | 10.12% | $ 162.11M |
| 3/31/2023 | $ 16.41M | 10.42% | $ 157.47M |
Key Performance Insights, Last 5 Years
- ANIKA THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 10.14%.
- Over the past 5 years, ANIKA THERAPEUTICS INC's average DepAmor % has been 10.11%.
- The median DepAmor % for ANIKA THERAPEUTICS INC during this period was 10.28%
- ANIKA THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 12.22%.
- The lowest DepAmor % recorded by ANIKA THERAPEUTICS INC in the same timeframe 7.34%
ANIKA THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for ANIKA THERAPEUTICS INC is calculated as follows: DepAmor [ $ 12.93M ] / Revenues [ $ 127.54M ]
(=) DepAmor % [ 10.14% ] ANIK - Depreciation and Amortization Margin, Last 5 years
7.34%
Minimum
Sep 30, 2024
12.22%
Maximum
Mar 31, 2021
10.11%
Average
10.28%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |